A Short Intro for Marvell Technology Investors

Marvell Technology shares fell by -1.6% during the day's morning session, and are now trading at a price of $60.31. Is it time to buy the dip? To better answer that question, it's essential to check if the market is valuing the company's shares fairly in terms of its earnings and equity levels.

Marvell Technology Has an Attractive P/B Ratio but a Worrisome P/E Ratio:

Marvell Technology, Inc., together with its subsidiaries, provides data infrastructure semiconductor solutions, spanning the data center core to network edge. The company belongs to the Technology sector, which has an average price to earnings (P/E) ratio of 35.0 and an average price to book (P/B) ratio of 7.92. In contrast, Marvell Technology has a trailing 12 month P/E ratio of -92.8 and a P/B ratio of 3.42.

Marvell Technology's PEG ratio is 3.31, which shows that the stock is probably overvalued in terms of its estimated growth. For reference, a PEG ratio near or below 1 is a potential signal that a company is undervalued.

Increasing Revenues but Narrowing Margins:

2021 2022 2023
Revenue (MM) $2,969 $4,462 $5,919,600
Revenue Growth n/a 50.3% 132555.07%
Operating Margins -9% -8% 0%
Net Margins -9% -9% 100%
Net Income (MM) -$277 -$421 $5,919,600
Net Interest Expense (MM) $69 $139 -$153
Depreciation & Amort. (MM) $96 $266 $305
Earnings Per Share -$0.41 -$0.53 $851.4
EPS Growth n/a -29.27% 160741.51%
Diluted Shares (MM) 829 858 861
Free Cash Flow (MM) $710 $650 $1,083
Capital Expenditures (MM) $107 $169 $206
Current Ratio 1.81 1.31 1.03
Total Debt (MM) $4,557 $4,575 $4,738
Net Debt / EBITDA -24.82 -47.08 11.06

Marvell Technology has growing revenues and increasing reinvestment in the business, exceptional EPS growth, and irregular cash flows. However, the firm suffers from consistently negative margins with a negative growth trend and a highly leveraged balance sheet.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS